Ben Gil Price's Net Worth
$5.17 Million
Who is Ben Gil Price?
Ben Gil Price has an estimated net worth of $5.17 Million. This is based on reported shares across multiple companies, which include Sarepta Therapeutics, Inc., NeuroBo Pharmaceuticals, Inc., and REXAHN PHARMACEUTICALS, INC..
SEC CIK
Ben Gil Price's CIK is 0001417915
Past Insider Trading and Trends
2009 was Ben Gil Price's most active year for acquiring shares with 5 total transactions. Ben Gil Price's most active month to acquire stocks was the month of May. 2016 saw Ben Gil Price paying a total of $75,144.15 for 16,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sarepta Therapeutics, Inc. (SRPT) Snapshot price: $126.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.74% | 4.5K |
$16.70 | $75,144.15 | 42.83K |
Mar 14
| |||
Form 4
| +2.68% | 1K |
—
|
—
| 38.33K |
Feb 29
| |||
Form 4
| +2.75% | 1K |
—
|
—
| 37.33K |
Feb 27
| |||
Form 4
| +2.83% | 1K |
—
|
—
| 36.33K |
Feb 28
| |||
Form 4
| +1.44% | 500 |
$31.18 | $15,587.50 | 35.33K |
Aug 19
| |||
Form 4
| +2.96% | 1K |
—
|
—
| 34.83K |
Jun 4
| |||
Form 4
| +2.52% | 833 |
—
|
—
| 33.83K |
Aug 23
| |||
Form 4
| +17.86% | 30K |
$1.30 | $38,850.00 | 197.98K |
Mar 14
| |||
Form 4
| +3.07% | 5K |
—
|
—
| 167.98K |
Jun 21
| |||
Form 4
| +13.99% | 20K |
$1.50 | $30,000.00 | 162.98K |
Apr 6
| |||
Form 4
| +4.04% | 4K |
$1.93 | $7,720.00 | 102.98K |
Aug 13
| |||
Form 4
| +7.61% | 7K |
$1.44 | $10,080.00 | 98.98K |
Jun 11
| |||
Form 4
| +5.75% | 5K |
—
|
—
| 91.98K |
Jun 8
| |||
Form 4
| +45.99% | 40K |
$1.36 | $54,400.00 | 126.98K |
May 13
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| +6.10% | 5K |
—
|
—
| 86.98K |
May 19
| |||
Form 4
| +159.58% | 50.4K |
$0.66 | $33,079.68 | 81.98K |
Mar 13 - Mar 16
| |||
Form 4
| +26.33% | 6.58K |
$1.22 | $8,030.04 | 31.58K |
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeuroBo Pharmaceuticals, Inc. (NRBO) Snapshot price: $4.21
CEO and President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REXAHN PHARMACEUTICALS, INC. (OCUP) Snapshot price: $2.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
∞
| 15K |
$0.61 | $9,141.00 | 15K |
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||